SOURCE: Sunesis Pharmaceuticals, Inc.

Sunesis Pharmaceuticals, Inc.

November 11, 2010 07:30 ET

Sunesis Pharmaceuticals to Present at Lazard Capital Markets Annual Healthcare Conference

SOUTH SAN FRANCISCO, CA--(Marketwire - November 11, 2010) - Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will be presenting at the Lazard Capital Markets Annual Healthcare Conference on Tuesday, November 16, 2010 at 9:25 A.M. Eastern Time at the St. Regis Hotel in New York City.

A live webcast of this presentation will be available on the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks.

About Sunesis Pharmaceuticals

Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, vosaroxin, in multiple indications to improve the lives of people with cancer.

Contact Information

  • Investor and Media Inquiries:
    David Pitts
    Argot Partners
    212-600-1902

    Eric Bjerkholt
    Sunesis Pharmaceuticals, Inc.
    650-266-3717